STING1 and neoplasm: Injection of ‘free’ small molecule STING agonists can lead to rapid dissemination in the bloodstream resulting in uncontrolled inflammation and ‘cytokine storm’, tissue toxicity, autoimmunity and a promotion of tumour growth [119].